NASDAQ : IART
Integra LifeSciences Holdings Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 12.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 998.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 991.96M |
| Enterprise Value | 2.68B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 77.80M |
| Shares Outstanding | 77.80M |
| Shares Change (YoY) | +1.38% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 3.69% |
| Owned by Institutions (%) | 85.69% |
| Float | 58.64M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 75.92 |
| Forward PE | 5.47 |
| PS Ratio | 0.60 |
| Forward PS | 0.60 |
| PB Ratio | 0.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.56 |
| P/OCF Ratio | 7.07 |
| PEG Ratio | 1.24 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 206.20 |
| EV / Sales | 1.62 |
| EV / EBITDA | 8.44 |
| EV / EBIT | 16.39 |
| EV / FCF | 31.28 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.62 |
| Quick Ratio | 1.70 |
| Debt / Equity | 1.88 |
| Debt / EBITDA | 5.83 |
| Debt / FCF | 23.35 |
| Interest Coverage | 1.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.24% |
| Return on Assets (ROA) | 2.86% |
| Return on Invested Capital (ROIC) | 3.43% |
| Return on Capital Employed (ROCE) | 5.15% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | $374,246 |
| Profits Per Employee | $2,939 |
| Employee Count | 4,427 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.55 |
Taxes
| Measure | Value |
|---|
| Income Tax | 9.30M |
| Effective Tax Rate | 41.67% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -17.37% |
| 50-Day Moving Average | 14.84 |
| 200-Day Moving Average | 14.07 |
| Relative Strength Index (RSI) | 42.82 |
| Average Volume (20 Days) | 1,266,213 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.32M |
| Short Previous Month | 7.27M |
| Short % of Shares Out | 9.40% |
| Short % of Float | 12.48% |
| Short Ratio (days to cover) | 6.30 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.66B |
| Gross Profit | 919.84M |
| Operating Income | 163.76M |
| Pretax Income | 22.31M |
| Net Income | 13.01M |
| EBITDA | 317.82M |
| EBIT | 163.76M |
| Earnings Per Share (EPS) | $0.17 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 311.93M |
| Total Debt | 2.00B |
| Net Cash | -1.69B |
| Net Cash Per Share | -$21.74 |
| Equity (Book Value) | 1.07B |
| Book Value Per Share | 13.71 |
| Working Capital | 860.94M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 140.40M |
| Capital Expenditures | -54.62M |
| Depreciation & Amortization | 154.06M |
| Net Borrowing | -6.05M |
| Free Cash Flow | 85.78M |
| FCF Per Share | $1.10 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.52% |
| Operating Margin | 9.88% |
| Pretax Margin | 1.35% |
| Profit Margin | 0.79% |
| EBITDA Margin | 19.18% |
| EBIT Margin | 9.88% |
| FCF Margin | 5.18% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.38% |
| Shareholder Yield | -1.38% |
| Earnings Yield | 1.32% |
| FCF Yield | 8.65% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $15.67 |
| Price Target Difference | 22.90% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 2.04% |
| EPS Growth Forecast (3Y) | 3.09% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 4, 2017 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.36 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |